Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cigna Corp.
Even As PBMs Face Reckoning, Formulary Exclusions Rise Again In 2023
Congressional scrutiny aside, ‘the rebate model remains alive and well’ as the big three pharmacy benefit managers exclude around 600 drugs each from their formularies.
AHIP, PhRMA Try to Control Narrative as Heat on PBMs Intensifies
As health insurance lobby launches advertising campaign to defend ‘evidence-based, market-driven tools,’ drug firms point out the connection between insurers and pharmacy benefit managers.
Express Scripts Unveils New Co-Pay Cap For Generics Amid PBM Scrutiny
Cigna’s PBM, Express Scripts, is looking to “further align incentives across the pharmaceutical supply chain, consumers, and clients,” with a trio of new products available starting this summer.
Obesity Drug Coverage Should Not Be Required For ACA Plans, Cigna Tells CMS
Insurer's concerns about the cost of covering drugs that could be used by large swaths of the population has contributed to their reluctance to pay for them, but in comments to the agency, drug firms, consumer advocates and medical professionals urged the Centers for Medicare and Medicaid Services to promote coverage in the commercial plans governed by the Affordable Care Act.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.